SC
Samik Chakraborty
NE1 Inc., Boston Children's Hospital, University of Calcutta Department of Biochemistry, Harvard Medical School
0000-0002-5232-0474
Employment
-
NE1 Inc. Senior Scientist2022 - Present
-
Boston Children's Hospital Postdoctoral research fellow2015 - Present
-
Harvard Medical School https://connects.catalyst.harvard.edu/Profiles/display/Person/1449332015 - Present
-
MRC Toxicology Unit Postdoctoral Scientist2015 - 2015
-
Bose Institute - Centenary Campus Ph.D research fellow/ Graduate research assistant2008 - 2015
Education
-
University of Calcutta Department of Biochemistry Ph.D2008 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (37)
- The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies Save
- Optimizing rWTC-MBTA Vaccine Formulations, Dosing Regimens, and Cryopreservation Techniques to Enhance Anti-Metastatic Immunotherapy Save
- rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells Save
- Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy Save
- rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses Save
- The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review Save
- Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy Save
- Impact of smoking-induced dysregulated human miRNAs in chronic disease development and their potential use in prognostic and therapeutic purposes Save
- Engineered titania nanomaterials in advanced clinical applications Save
- A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation Save